These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6181646)

  • 21. Demonstration of complex antigenic heterogeneity in a human glioma cell line and eight derived clones by specific monoclonal antibodies.
    Wikstrand CJ; Bigner SH; Bigner DD
    Cancer Res; 1983 Jul; 43(7):3327-34. PubMed ID: 6303581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sandwich radioimmunoassay using single monoclonal antibody that detects minute amounts of melanoma antigens from various mammalian species.
    Wakabayashi S; Okamoto S; Taniguchi M
    Gan; 1984 May; 75(5):427-32. PubMed ID: 6204903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigenic heterogeneity of human anaplastic gliomas and glioma-derived cell lines defined by monoclonal antibodies.
    Wikstrand CJ; Grahmann FC; McComb RD; Bigner DD
    J Neuropathol Exp Neurol; 1985 May; 44(3):229-41. PubMed ID: 2580959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas.
    Chi DD; Merchant RE; Rand R; Conrad AJ; Garrison D; Turner R; Morton DL; Hoon DS
    Am J Pathol; 1997 Jun; 150(6):2143-52. PubMed ID: 9176405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ocular tumors react with anti-neuroblastoma monoclonal antibodies.
    Helson C; Helson L
    Invest Ophthalmol Vis Sci; 1983 Aug; 24(8):1150-2. PubMed ID: 6874279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Syngeneic monoclonal antibodies against melanoma antigens with species specificity and interspecies cross-reactivity.
    Wakabayashi S; Saito T; Shinohara N; Okamoto S; Tomioka H; Taniguchi M
    J Invest Dermatol; 1984 Aug; 83(2):128-33. PubMed ID: 6206164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal antibodies reactive with glioma cell lines derived from experimental brain tumors.
    Stavrou D; Süss C; Bilzer T; Kummer U; De Tribolet N
    Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1439-49. PubMed ID: 6196200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Common human melanoma-associated antigen(s) detected by monoclonal antibodies.
    Carrel S; Accolla RS; Carmagnola AL; Mach JP
    Cancer Res; 1980 Jul; 40(7):2523-8. PubMed ID: 6155995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serological survey of normal humans for natural antibody to cell surface antigens of melanoma.
    Houghton AN; Taormina MC; Ikeda H; Watanabe T; Oettgen HF; Old LJ
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4260-4. PubMed ID: 6933476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunotherapeutic targeting of shared melanoma-associated antigens in a murine glioma model.
    Prins RM; Odesa SK; Liau LM
    Cancer Res; 2003 Dec; 63(23):8487-91. PubMed ID: 14679014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody.
    Bourdon MA; Wikstrand CJ; Furthmayr H; Matthews TJ; Bigner DD
    Cancer Res; 1983 Jun; 43(6):2796-805. PubMed ID: 6342760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-reactive human immunoglobulin G monoclonal antibody from a melanoma patient.
    Kan-Mitchell J; White WL; Mitchell MS
    Cancer Res; 1989 Aug; 49(16):4536-41. PubMed ID: 2472881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight melanoma associated antigen.
    Ziai MR; Imberti L; Nicotra MR; Badaracco G; Segatto O; Natali PG; Ferrone S
    Cancer Res; 1987 May; 47(9):2474-80. PubMed ID: 3552215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterisation of a new mouse monoclonal antibody (ONS-M21) reactive with both medulloblastomas and gliomas.
    Moriuchi S; Shimizu K; Miyao Y; Hayakawa T
    Br J Cancer; 1993 Nov; 68(5):831-7. PubMed ID: 8217597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review of melanoma antigens recognized by monoclonal antibodies (MAbs). Their functional significance and applications in diagnosis and treatment of melanoma.
    Hersey P
    Pathology; 1985 Apr; 17(2):346-54. PubMed ID: 4047738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The expression of tumor-associated antigens in primary and metastatic human malignant melanoma.
    Brüggen J; Bröcker EB; Suter L; Redmann K; Sorg C
    Behring Inst Mitt; 1984 May; (74):19-23. PubMed ID: 6477352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human melanoma-specific oncofetal antigen defined by a mouse monoclonal antibody.
    Liao SK; Clarke BJ; Khosravi M; Kwong PC; Brickenden A; Dent PB
    Int J Cancer; 1982 Nov; 30(5):573-80. PubMed ID: 7152720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human monoclonal antibody to a neuroectodermal tumor antigen (OFA-I-2).
    Katano M; Sidell N; Irie RF
    Ann N Y Acad Sci; 1983; 417():427-34. PubMed ID: 6584083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-reactivity of murine anti-human high molecular weight-melanoma associated antigen monoclonal antibodies with guinea pig melanoma cells.
    Liao SK; Smith JW; Kwong PC; Natali PG; Kusama M; Hamby CV; Ferrone S
    Cancer Res; 1987 Sep; 47(18):4835-41. PubMed ID: 3476198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigenic heterogeneity of human brain tumors defined by monoclonal antibodies.
    Stavrou D; Bise K; Groeneveld J; Stocker U; Kretzschmar HA; Keiditsch E; Mehraein P
    Anticancer Res; 1989; 9(6):1489-96. PubMed ID: 2697177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.